Acute Lymphoblastic Leukemia: Risk Stratification

1 意见
administrator
administrator
06/15/23

Mark R. Litzow, MD; Ryan D. Cassaday, MD; Aaron C. Logan, MD, PhD; Bijal D. Shah, MD; and Anthony S. Stein, MD, reflect on the complexities of the risk stratification process in acute lymphoblastic leukemia, incorporating patient age, molecular subtype, and minimal residual disease status.

  • 类别

显示更多

0 注释 排序方式

没有找到评论

脸书评论

下一个